Findings

What do systematic reviews say?

4,783 questions · 10,022 findings · 882 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2,100 · 21%GRADE not reported 1,013 · 10.1%Very low 2,237 · 22.3%Low 2,514 · 25.1%Moderate 1,709 · 17.1%High 449 · 4.5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Foam vs sclerotherapy (any sclerosant)

Time to resolution · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Foam vs sclerotherapy (any sclerosant)

Quality of life · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Laser therapy vs sclerotherapy (any sclerosant)

Resolution or improvement of telangiectasias ( · people with telangiectasias and reticular veins

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 593 participants
Moderate

Laser therapy vs sclerotherapy (any sclerosant)

Adverse events ‐ hyperpigmentation ( · people with telangiectasias and reticular veins

Laser probably leads to lower adverse events ‐ hyperpigmentation ( compared with sclerotherapy (moderate certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 0.57 [0.4, 0.8]
4 studies · 262 participants
Moderate

Laser therapy vs sclerotherapy (any sclerosant)

Adverse events ‐ matting ( · people with telangiectasias and reticular veins

Laser showed no clear difference in adverse events ‐ matting ( compared with sclerotherapy (moderate certainty).

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
RR 1 [0.46, 2.19]
2 studies · 162 participants
Moderate

Laser therapy vs sclerotherapy (any sclerosant)

Pain ( · people with telangiectasias and reticular veins

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 100 participants
Low

Laser therapy vs sclerotherapy (any sclerosant)

Recurrence · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Laser therapy vs sclerotherapy (any sclerosant)

Time to resolution · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Laser therapy vs sclerotherapy (any sclerosant)

Quality of life · people with telangiectasias and reticular veins

The review found no eligible studies for this question.

1 finding from 1 review

Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Sunlight (with or without filters or amplification) vs other sources of phototherapy

Treatment failure requiring exchange transfusionc,d · infants with confirmed hyperbilirubinemia

Sunlight (with or without filters or amplification) showed no clear difference in treatment failure requiring exchange transfusionc,d compared with other sources of phototherapy (low certainty).

1 finding from 1 review

Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates 2021 · Cochrane Headline outcomes only
RR 1 [0.06, 15.73]
2 studies · 621 participants
Low

Sunlight (with or without filters or amplification) vs other sources of phototherapy

Acute bilirubin encephalopathy · infants with confirmed hyperbilirubinemia

Sunlight (with or without filters or amplification) may leads to lower acute bilirubin encephalopathyc,f compared with other sources of phototherapy (low certainty).

1 finding from 1 review

Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates 2021 · Cochrane Headline outcomes only
RR 0
1 study · 174 participants
Low

Sunlight (with or without filters or amplification) vs other sources of phototherapy

Deathc · infants with confirmed hyperbilirubinemia

Sunlight (with or without filters or amplification) may leads to lower deathc compared with other sources of phototherapy (low certainty).

1 finding from 1 review

Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates 2021 · Cochrane Headline outcomes only
RR 0
1 study · 447 participants
Low

Sunlight (with or without filters or amplification) vs other sources of phototherapy

Proportion of days of effective treatmenti · infants with confirmed hyperbilirubinemia

It is very uncertain whether sunlight (with or without filters or amplification) changes proportion of days of effective treatmenti compared with other sources of phototherapy (very low certainty).

1 finding from 1 review

Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates 2021 · Cochrane Headline outcomes only
RR 1.02 [0.97, 1.06]
2 studies · 621 participants
Very low

Sunlight (with or without filters or amplification) vs other sources of phototherapy

Outcomesa · infants with confirmed hyperbilirubinemia

The review found no eligible studies for this question.

1 finding from 1 review

Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga vs no treatment (both groups received standard medical therapy)

Treatment success as defined by the authors · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga vs no treatment (both groups received standard medical therapy)

Abdominal pain frequency or change in frequency · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga vs no treatment (both groups received standard medical therapy)

Abdominal pain intensity or change in intensity · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga vs no treatment (both groups received standard medical therapy)

Withdrawals due to adverse events · people with inflammatory bowel disease

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 100 participants
Very low

Topical triamcinolone acetonide vs Photodynamic therapy

Clinical score · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment

Topical triamcinolone acetonide may leads to higher clinical score compared with photodynamic therapy (low certainty).

1 finding from 1 review

Interventions for treating oral lichen planus: corticosteroid therapies 2020 · Cochrane All outcomes
MD 1.52 [0.17, 2.87]
1 study · 20 participants
Low

Dexamethasone mouthwash plus nystatin vs Photodynamic therapy

Clinical resolution · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment

1 finding from 1 review

Interventions for treating oral lichen planus: corticosteroid therapies 2020 · Cochrane All outcomes
Bakhtiari 2017 (dexamethasone mouthwash + nystatin vs photodynamic therapy): clinical resolution reported (Analysis 4.6); no clear difference (low to very low certainty collectively)
1 study
GRADE not reported